Ágnes Holczbauer

1.1k total citations
18 papers, 727 citations indexed

About

Ágnes Holczbauer is a scholar working on Molecular Biology, Hepatology and Neurology. According to data from OpenAlex, Ágnes Holczbauer has authored 18 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Hepatology and 5 papers in Neurology. Recurrent topics in Ágnes Holczbauer's work include Liver physiology and pathology (5 papers), Barrier Structure and Function Studies (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Ágnes Holczbauer is often cited by papers focused on Liver physiology and pathology (5 papers), Barrier Structure and Function Studies (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Ágnes Holczbauer collaborates with scholars based in United States, Hungary and Italy. Ágnes Holczbauer's co-authors include Jens U. Marquardt, Daekwan Seo, Snorri S. Thorgeirsson, Valentina M. Factor, Jesper B. Andersen, András Kiss, Chiara Raggi, Péter Kupcsulik, Mitsuteru Kitade and Zsuzsa Schaff and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ágnes Holczbauer

18 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ágnes Holczbauer United States 14 353 221 206 201 190 18 727
Tamako Konkin United States 7 319 0.9× 233 1.1× 126 0.6× 57 0.3× 213 1.1× 8 762
Yuichi Sanada Japan 14 235 0.7× 244 1.1× 167 0.8× 37 0.2× 115 0.6× 30 576
Seiji Naganuma Japan 16 429 1.2× 242 1.1× 193 0.9× 117 0.6× 236 1.2× 38 795
Xianchun Yan China 13 305 0.9× 87 0.4× 62 0.3× 84 0.4× 161 0.8× 27 569
Zhiyong Du China 15 318 0.9× 217 1.0× 210 1.0× 100 0.5× 188 1.0× 38 676
Xiangwei Meng China 15 188 0.5× 127 0.6× 82 0.4× 49 0.2× 83 0.4× 38 435
Tianxiao Gao China 12 268 0.8× 171 0.8× 45 0.2× 69 0.3× 117 0.6× 19 531
Silke Götze Germany 12 403 1.1× 105 0.5× 217 1.1× 255 1.3× 132 0.7× 19 731
Sheng Han China 17 355 1.0× 100 0.5× 93 0.5× 43 0.2× 200 1.1× 33 586
Hideaki Oe Japan 8 203 0.6× 94 0.4× 65 0.3× 103 0.5× 163 0.9× 18 382

Countries citing papers authored by Ágnes Holczbauer

Since Specialization
Citations

This map shows the geographic impact of Ágnes Holczbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ágnes Holczbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ágnes Holczbauer more than expected).

Fields of papers citing papers by Ágnes Holczbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ágnes Holczbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ágnes Holczbauer. The network helps show where Ágnes Holczbauer may publish in the future.

Co-authorship network of co-authors of Ágnes Holczbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Ágnes Holczbauer. A scholar is included among the top collaborators of Ágnes Holczbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ágnes Holczbauer. Ágnes Holczbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Hongru, Ágnes Holczbauer, Zhen Lu, et al.. (2024). PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies. Cell Reports Medicine. 5(7). 101649–101649. 3 indexed citations
2.
Preziosi, Morgan, Dali Yin, Ágnes Holczbauer, et al.. (2022). In Vivo Screen Identifies Liver X Receptor Alpha Agonism Potentiates Sorafenib Killing of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 1(5). 905–908. 6 indexed citations
3.
Grattarola, Margherita, Ágnes Holczbauer, Rosanna Dono, et al.. (2022). MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities. Cell Death and Disease. 13(11). 994–994. 18 indexed citations
4.
Holczbauer, Ágnes, Kirk J. Wangensteen, & Soona Shin. (2021). Cellular origins of regenerating liver and hepatocellular carcinoma. JHEP Reports. 4(4). 100416–100416. 26 indexed citations
5.
Raggi, Chiara, Valentina M. Factor, Daekwan Seo, et al.. (2014). Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology. 59(6). 2251–2262. 68 indexed citations
6.
Holczbauer, Ágnes, Benedek Gyöngyösi, Gábor Lotz, et al.. (2014). Increased Expression of Claudin-1 and Claudin-7 in Liver Cirrhosis and Hepatocellular Carcinoma. Pathology & Oncology Research. 20(3). 493–502. 25 indexed citations
7.
Kitade, Mitsuteru, Valentina M. Factor, Jesper B. Andersen, et al.. (2013). Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes & Development. 27(15). 1706–1717. 80 indexed citations
8.
Holczbauer, Ágnes, Valentina M. Factor, Jesper B. Andersen, et al.. (2013). Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types. Gastroenterology. 145(1). 221–231. 134 indexed citations
9.
Holczbauer, Ágnes, Benedek Gyöngyösi, Gábor Lotz, et al.. (2013). Distinct Claudin Expression Profiles of Hepatocellular Carcinoma and Metastatic Colorectal and Pancreatic Carcinomas. Journal of Histochemistry & Cytochemistry. 61(4). 294–305. 28 indexed citations
10.
Lee, Seung Bum, Daekwan Seo, Dongho Choi, et al.. (2012). Contribution of Hepatic Lineage Stage‐Specific Donor Memory to the Differential Potential of Induced Mouse Pluripotent Stem Cells. Stem Cells. 30(5). 997–1007. 47 indexed citations
11.
Marquardt, Jens U., Chiara Raggi, Jesper B. Andersen, et al.. (2011). Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology. 54(3). 1031–1042. 63 indexed citations
12.
Nemes, Balázs, Attila Doros, Ágnes Holczbauer, et al.. (2009). Expression pattern of molecular chaperones after liver transplantation in hepatitis C positive recipients. Relation to serum HCV-RNA titers. Interventional Medicine and Applied Science. 1(1). 35–40. 5 indexed citations
13.
Szabó, Liliána, Éva Korpos, Enkhjargal Batmunkh, et al.. (2008). Expression of Matrilin-2 in Liver Cirrhosis and Hepatocellular Carcinoma. Pathology & Oncology Research. 14(1). 15–22. 27 indexed citations
14.
Holczbauer, Ágnes, Enkhjargal Batmunkh, Attila Szíjártó, et al.. (2007). [431] HUMAN HEPATOCELLULAR CARCINOMA IS CHARACTERIZED BY DIFFERENT CLAUDIN EXPRESSION PATTERN WITH RESPECT TO CIRRHOSIS AND HCV INFECTION. Journal of Hepatology. 46. S165–S165. 1 indexed citations
15.
Batmunkh, Enkhjargal, Péter Tátrai, Liliána Szabó, et al.. (2007). Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Human Pathology. 38(10). 1508–1515. 35 indexed citations
16.
Szabó, Liliána, Ágnes Holczbauer, Enkhjargal Batmunkh, et al.. (2006). Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Modern Pathology. 19(3). 460–469. 78 indexed citations
17.
Holczbauer, Ágnes, et al.. (2006). Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma. Human Pathology. 37(5). 555–561. 34 indexed citations
18.
Győrffy, Hajnalka, Ágnes Holczbauer, Péter Kupcsulik, et al.. (2005). Claudin expression in Barrett's esophagus and adenocarcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 447(6). 961–968. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamako Konkin Breakdown of academic impact, for papers by Yuichi Sanada Breakdown of academic impact, for papers by Seiji Naganuma Breakdown of academic impact, for papers by Xianchun Yan Breakdown of academic impact, for papers by Zhiyong Du Breakdown of academic impact, for papers by Xiangwei Meng Breakdown of academic impact, for papers by Tianxiao Gao Breakdown of academic impact, for papers by Silke Götze Breakdown of academic impact, for papers by Sheng Han Breakdown of academic impact, for papers by Hideaki Oe
Rankless by CCL
2026